Influence of physiologic folate deficiency on human papillomavirus type 16 (HPV16)-harboring human keratinocytes in vitro and in vivo

J Biol Chem. 2012 Apr 6;287(15):12559-77. doi: 10.1074/jbc.M111.317040. Epub 2012 Feb 17.

Abstract

Although HPV16 transforms infected epithelial tissues to cancer in the presence of several co-factors, there is insufficient molecular evidence that poor nutrition has any such role. Because physiological folate deficiency led to the intracellular homocysteinylation of heterogeneous nuclear ribonucleoprotein E1 (hnRNP-E1) and activated a nutrition-sensitive (homocysteine-responsive) posttranscriptional RNA operon that included interaction with HPV16 L2 mRNA, we investigated the functional consequences of folate deficiency on HPV16 in immortalized HPV16-harboring human (BC-1-Ep/SL) keratinocytes and HPV16-organotypic rafts. Although homocysteinylated hnRNP-E1 interacted with HPV16 L2 mRNA cis-element, it also specifically bound another HPV16 57-nucleotide poly(U)-rich cis-element in the early polyadenylation element (upstream of L2L1 genes) with greater affinity. Together, these interactions led to a profound reduction of both L1 and L2 mRNA and proteins without effects on HPV16 E6 and E7 in vitro, and in cultured keratinocyte monolayers and HPV16-low folate-organotypic rafts developed in physiological low folate medium. In addition, HPV16-low folate-organotypic rafts contained fewer HPV16 viral particles, a similar HPV16 DNA viral load, and a much greater extent of integration of HPV16 DNA into genomic DNA when compared with HPV16-high folate-organotypic rafts. Subcutaneous implantation of 18-day old HPV16-low folate-organotypic rafts into folate-replete immunodeficient mice transformed this benign keratinocyte-derived raft tissue into an aggressive HPV16-induced cancer within 12 weeks. Collectively, these studies establish a likely molecular linkage between poor folate nutrition and HPV16 and predict that nutritional folate and/or vitamin-B(12) deficiency, which are both common worldwide, will alter the natural history of HPV16 infections and also warrant serious consideration as reversible co-factors in oncogenic transformation of HPV16-infected tissues to cancer.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Base Sequence
  • Capsid Proteins / genetics
  • Capsid Proteins / metabolism
  • Catalase / biosynthesis
  • Catalase / genetics
  • Cell Culture Techniques
  • Cell Proliferation
  • Cell Transformation, Viral*
  • Cells, Cultured
  • DNA-Binding Proteins
  • Female
  • Folic Acid / metabolism
  • Folic Acid Deficiency*
  • Genes, Reporter
  • Heterogeneous-Nuclear Ribonucleoproteins / chemistry
  • Heterogeneous-Nuclear Ribonucleoproteins / genetics
  • Heterogeneous-Nuclear Ribonucleoproteins / metabolism
  • Homocysteine / chemistry
  • Homocysteine / metabolism
  • Host-Pathogen Interactions
  • Human papillomavirus 16 / genetics
  • Human papillomavirus 16 / physiology*
  • Humans
  • Keratinocytes / metabolism
  • Keratinocytes / transplantation
  • Keratinocytes / virology*
  • Mice
  • Mice, Nude
  • Molecular Sequence Data
  • Neoplasms, Experimental / pathology
  • Neoplasms, Experimental / virology*
  • Oncogene Proteins, Viral / genetics
  • Oncogene Proteins, Viral / metabolism
  • Papillomavirus Infections / virology*
  • Protein Binding
  • Proteolysis
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / chemistry
  • RNA, Viral / chemistry
  • RNA, Viral / metabolism
  • RNA-Binding Proteins
  • Sulfhydryl Compounds / metabolism
  • Tumor Burden
  • Virus Integration

Substances

  • Capsid Proteins
  • DNA-Binding Proteins
  • Heterogeneous-Nuclear Ribonucleoproteins
  • L2 protein, Human papillomavirus type 16
  • Oncogene Proteins, Viral
  • PCBP1 protein, human
  • RNA, Messenger
  • RNA, Viral
  • RNA-Binding Proteins
  • Sulfhydryl Compounds
  • Homocysteine
  • L1 protein, Human papillomavirus type 16
  • Folic Acid
  • Catalase